Survival Analysis of Newly Diagnosed Multiple Myeloma Patients after Frontline Autologous Stem Cell Transplantation in a Real-Life Setting
CONCLUSION: ASCT is a feasible, safe, and potent strategy that provides a prolonged median OS and PFS in NDMM patients. This approach can be implemented in low-income countries.PMID:38511422 | DOI:10.14712/18059694.2024.4
Source: Acta Medica: Hradec Kralove - Category: General Medicine Authors: David Garrido Virginia Bove Fiorella Villano Elo ísa Riva Source Type: research
More News: General Medicine | Myeloma | Stem Cell Therapy | Stem Cells | Study | Transplants | Uruguay Health | Velcade